JW Therapeutics targets Hong Kong listing

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Asia

JW Therapeutics targets Hong Kong listing

Jonathan Breen
August 17, 2020 07:30 AM
biopharma_stocks_adobe_575x375.jpg
Healthcare medical biopharmaceutical investing stock chart background | Kurhan - stock.adobe.com

Chinese biotechnology company JW (Cayman) Therapeutics is planning to float on Hong Kong’s stock exchange. It has filed a draft prospectus with the bourse.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Equity IPOsHealth and BiotechUBSEquityChinaHong Kong SARAsiaGreater ChinaNortheast AsiaAsia PacificEmerging MarketsSRIGoldman Sachs
JB
Jonathan Breen
Equities editor GlobalCapital Asia
Contact
Gift this article